This ADC product is composed of an anti-CD66e antibody conjugated via linker to SN38 (anti-CD66e-SN38). It is in Phase I clinical trials and has demonstrated a response in colorectal cancer treatment by a MOA (Mechanism of Action) of binding to DNA minor groove and causing sequence-specific double-strand DNA cleavage.
Download resources about recombinant antibody development and antibody engineering to boost your research.
Select a product category from the dropdown menu below to view related products.
CAT | Product Name | Application | Type |
---|---|---|---|
MOB-1138z | Mouse Anti-CEACAM5 Recombinant Antibody (clone 32B10) | WB, IP, IF, FC | Mouse IgG1, κ |
HPAB-0155-FY | Mouse Anti-CEACAM5 Recombinant Antibody (HPAB-0155-FY) | Activ, FuncS | Humanized IgG1, κ |
HPAB-0243-FY | Human Anti-CEACAM5 Recombinant Antibody (HPAB-0243-FY) | ELISA, FuncS | Chimeric (mouse/human) IgG1 |
VS3-FY368 | Recombinant Mouse Anti-CEACAM5 Antibody (clone 10D8-8G10-2A3) | IHC-P | Mouse IgG2b |
VS-0723-WK269 | Rabbit Anti-CEACAM5 Recombinant Antibody (VS-0723-WK269) | ELISA, FC | Rabbit IgG |
There are currently no Customer reviews or questions for ADC-122LZY. Click the button above to contact us or submit your feedback about this product.
For Research Use Only. Not For Clinical Use.
For research use only. Not intended for any clinical use. No products from Creative Biolabs may be resold, modified for resale or used to manufacture commercial products without prior written approval from Creative Biolabs.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.